Skip to main content

Guaifenesin 200mg

NDC 10135-789 · Marlex Pharmaceuticals Inc

Generic nameGuaifenesin
Dosage formTABLET
RouteORAL
Active ingredient(s)GUAIFENESIN
Strength200 mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
Marketing categoryOTC MONOGRAPH DRUG

Packages

10135-789-01 — 100 TABLET in 1 BOTTLE (10135-789-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0682-0475 — CODEINE PHOSPHATE and GUAIFENESIN, 0904-5154 — Guaifenesin, 0904-6537 — Dextromethorphan HBr, Guaifenesin, Phenylephrine, 0904-6718 — Guaifenesin, 0904-6986 — Guaifenesin, 0904-7223 — dextromethorphan hydrobromide, guaifenesin, 0904-7441 — Dextromethorphan HBr, Guaifenesin, 0904-7512 — Guaifenesin and Dextromethorphan, 0904-7513 — Guaifenesin and Dextromethorphan, 0924-0142 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, 10135-790 — Guaifenesin, 10202-740 — Dextromethorphan HBr, Guaifenesin, 10956-059 — Guaifenesin, 10956-845 — Guaifenesin, 10956-846 — Dextromethorphan Hydrobromide / Guaifenesin, 11383-311 — Dextromethorphan HBr, Guaifenesin, 11523-0094 — Acetaminophen, Guaifenesin, 11673-267 — Guaifenesin and Dextromethorphan HBr, 11673-337 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, 11673-347 — acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl, +1437 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels